Veralox scores $5.4 mln seed
Frederick, Maryland-based Veralox Therapeutics, a preclinical stage company, has raised $5.4 million in seed funding. JDRF T1D Fund, Sanofi Ventures and the VTC Innovation and VTC Seed Fund led the round with participation from the Maryland Momentum Fund, the University of Vermont Health Network and TEDCO.
5 September 2019•1 min read
